Literature DB >> 28715646

L-form bacteria cohabitants in human blood: significance for health and diseases.

Nadya D Markova1.   

Abstract

From a historical perspective, intriguing assumptions about unknown "live units" in human blood have attracted the attention of researchers, reflecting their desire to define a new class of microorganisms. Thus, the concept of "blood microbiota" brings about many questions about the nature, origin, and biological significance of the "unusual microbial cohabitants" in human blood. In contrast to current views that bloodstream in healthy humans is sterile, the hypothesis about the existence of microbes as L-forms (cell wall deficient bacteria) in human blood has evolved on the basis of known facts about their unique biology, as observed in our studies and those of other authors. Recently, we reported that bacterial L-forms persist in the human blood and that filterable, self-replicating bodies with a virus-like size of 100 nm are able to cross the maternal-fetal barrier by vertically transmitted pathway, then enter fetus blood circulation and colonize newborns. Subjects discussed here include the following: Is the existence of L-form bacteria in human blood a natural phenomenon? Are L-form bacteria commensal cohabitants in the human body? Since blood is an unfavorable compartment for the classical bacteria and their propagation, how do L-forms survive in blood circulation? How does L-form microbiota in blood influence the host immune system and contribute to systemic inflammatory, autoimmune, and tumor diseases? The current commentary presents the topic of "human microbiota and L-form bacteria" in its microcosm. It contains details of the hypothesis, supporting evidence and important implications.

Entities:  

Mesh:

Year:  2017        PMID: 28715646

Source DB:  PubMed          Journal:  Discov Med        ISSN: 1539-6509            Impact factor:   2.970


  10 in total

1.  The Gut and Blood Microbiome in IgA Nephropathy and Healthy Controls.

Authors:  Neal B Shah; Sagar U Nigwekar; Sahir Kalim; Benjamin Lelouvier; Florence Servant; Monika Dalal; Scott Krinsky; Alessio Fasano; Nina Tolkoff-Rubin; Andrew S Allegretti
Journal:  Kidney360       Date:  2021-06-09

Review 2.  Circulating Microbiota in Cardiometabolic Disease.

Authors:  Keiichi Sumida; Zhongji Han; Chi-Yang Chiu; Tahliyah S Mims; Amandeep Bajwa; Ryan T Demmer; Susmita Datta; Csaba P Kovesdy; Joseph F Pierre
Journal:  Front Cell Infect Microbiol       Date:  2022-05-03       Impact factor: 6.073

Review 3.  Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the Era of the Human Microbiome: Persistent Pathogens Drive Chronic Symptoms by Interfering With Host Metabolism, Gene Expression, and Immunity.

Authors:  Amy Proal; Trevor Marshall
Journal:  Front Pediatr       Date:  2018-12-04       Impact factor: 3.418

4.  Association between blood microbiome and type 2 diabetes mellitus: A nested case-control study.

Authors:  Jing Qiu; Hui Zhou; Yang Jing; Chen Dong
Journal:  J Clin Lab Anal       Date:  2019-02-04       Impact factor: 2.352

5.  Dysbiotic microbiota in autistic children and their mothers: persistence of fungal and bacterial wall-deficient L-form variants in blood.

Authors:  N Markova
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379

6.  Generating Heterokaryotic Cells via Bacterial Cell-Cell Fusion.

Authors:  Shraddha Shitut; Meng-Jie Shen; Bart Claushuis; Rico J E Derks; Martin Giera; Daniel Rozen; Dennis Claessen; Alexander Kros
Journal:  Microbiol Spectr       Date:  2022-07-14

Review 7.  Human circulating bacteria and dysbiosis in non-infectious diseases.

Authors:  Mohsan Ullah Goraya; Rui Li; Abdul Mannan; Liming Gu; Huixiong Deng; Gefei Wang
Journal:  Front Cell Infect Microbiol       Date:  2022-08-24       Impact factor: 6.073

8.  Multi-Method Characterization of the Human Circulating Microbiome.

Authors:  Emma Whittle; Martin O Leonard; Rebecca Harrison; Timothy W Gant; Daniel Paul Tonge
Journal:  Front Microbiol       Date:  2019-01-17       Impact factor: 5.640

9.  Study on antibiotic susceptibility of Salmonella typhimurium L forms to the third and forth generation cephalosporins.

Authors:  Cuiping Yang; Huihui Li; Tao Zhang; Yifan Chu; Junli Zuo; Dengyu Chen
Journal:  Sci Rep       Date:  2020-02-20       Impact factor: 4.379

10.  Molecular characterisation of the synovial fluid microbiome in rheumatoid arthritis patients and healthy control subjects.

Authors:  Dargham Bayan Mohsen Hammad; Veranja Liyanapathirana; Daniel Paul Tonge
Journal:  PLoS One       Date:  2019-11-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.